New Guidelines for Severe Community-acquired Pneumonia

Semin Respir Crit Care Med. 2024 Apr;45(2):274-286. doi: 10.1055/s-0043-1777797. Epub 2024 Mar 1.

Abstract

In 2023, the new European guidelines on severe community-acquired pneumonia, providing clinical practice recommendations for the management of this life-threatening infection, characterized by a high burden of mortality, morbidity, and costs for the society. This review article aims to summarize the principal evidence related to eight different questions covered in the guidelines, by also highlighting the future perspectives for research activity.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Community-Acquired Infections* / drug therapy
  • Humans
  • Pneumonia* / drug therapy

Substances

  • Anti-Bacterial Agents